You are here: All Products  > Merck Announces China Erbitux Approval for Head and Neck Cancer

Merck Announces China Erbitux Approval for Head and Neck Cancer

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products